A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM

NCT04198480 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercalcemia of Malignancy

Interventions

DRUG: JMT103

Sponsor

Shanghai JMT-Bio Inc.

Collaborators

[object Object]